Szerző: " Mathuber Marlene"

Dömötör Orsolya; Mathuber Marlene; Kowol Christian R.: In vitro biodistribution studies on clinically approved FGFR inhibitors ponatinib, nintedanib, erlotinib and the investigational inhibitor KP2692.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 192. ISSN 0928-0987 (2024)

Pósa Vivien; Stefanelli Alessia; Nunes Julia H. Bormio; Hager Sonja; Mathuber Marlene; May Nóra Veronika; Berger Walter; Keppler Bernhard K.; Kowol Christian R.; Enyedy Éva Anna; Heffeter Petra: Thiosemicarbazone Derivatives Developed to Overcome COTI-2 Resistance.
CANCERS, 14 (18). Terjedelem: 27 p.-Azonosító: 4455. ISSN 2072-6694 (2022)

Bormio Nunes Julia H.; Hager Sonja; Mathuber Marlene; Pósa Vivien; Roller Alexander; Enyedy Éva Anna; Stefanelli Alessia; Berger Walter; Keppler Bernhard K.; Heffeter Petra; Kowol Christian R.: Cancer Cell Resistance Against the Clinically Investigated Thiosemicarbazone COTI-2 Is Based on Formation of Intracellular Copper Complex Glutathione Adducts and ABCC1-Mediated Efflux.
JOURNAL OF MEDICINAL CHEMISTRY, 63. pp. 13719-13732. ISSN 0022-2623 (2020)

Mathuber Marlene; Schueffl Hemma; Dömötör Orsolya; Karnthaler Claudia; Enyedy Éva Anna; Heffeter Petra; Kowol Christian R.: Improving the Stability of EGFR Inhibitor Cobalt(III) Prodrugs.
INORGANIC CHEMISTRY, 59 (23). pp. 17794-17810. ISSN 0020-1669 (2020)